Synthesis and Anti-Hepatitis B Activities of 3'-Fluoro-2'-Substituted Apionucleosides. 2022

Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
Janssen Research and Development, LLC, South San Francisco, CA 94080, USA.

Nucleoside analogues have excellent records as anti-HBV drugs. Chronic infections require long-term administration ultimately leading to drug resistance. Therefore, the search for nucleosides with novel scaffolds is of high importance. Here we report the synthesis of novel 2'-hydroxy- and 2'-hydroxymethyl-apionucleosides, 4 and 5, corresponding triphosphates and phosphoramidate prodrugs. Triphosphate 38 of 2'-hydroxymethyl-apionucleoside 5 exhibited potent inhibition of HBV polymerase with an IC50 value of 120 nM. In an HBV cell-based assay, the phosphoramidate prodrug 39 demonstrated potent activity with an EC50 value of 7.8 nM.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D011355 Prodrugs A compound that, on administration, must undergo chemical conversion by metabolic processes before becoming the pharmacologically active drug for which it is a prodrug. Drug Precursor,Drug Precursors,Pro-Drug,Prodrug,Pro-Drugs,Precursor, Drug,Precursors, Drug,Pro Drug,Pro Drugs
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral

Related Publications

Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
April 1999, Journal of medicinal chemistry,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
July 2007, Organic letters,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
March 2012, Medicinal chemistry (Shariqah (United Arab Emirates)),
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
November 2010, Bioorganic & medicinal chemistry,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
January 2019, Organic & biomolecular chemistry,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
January 1998, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
July 1988, Biochemical pharmacology,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
February 2002, Biological & pharmaceutical bulletin,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
August 1997, Journal of medicinal chemistry,
Martin Holan, and Kathryn Tucker, and Natalia Dyatkina, and Hong Liu, and April Kinkade, and Guangyi Wang, and Zhinan Jin, and Marija Prhavc
July 2016, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!